ND06983
DNA from Whole Blood
Description:
CEREBRAL INFARCTION, SILENT
|
Repository
|
NINDS Repository
|
| Subcollection |
Cerebrovascular Disease |
| Quantity |
3 µg |
| Quantitation Method |
Please see our FAQ |
|
Biopsy Source
|
Peripheral vein
|
|
Sample Source
|
DNA from Whole Blood
|
|
Race
|
Black/African American
|
|
Ethnicity
|
Not Hispanic/Latino
|
|
Country of Origin
|
USA
|
|
Family History
|
Y
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Note
|
This material represents a finite resource (DNA from Whole Blood)
|
| Limdi NA, Brown TM, Yan Q, Thigpen JL, Shendre A, Liu N, Hill CE, Arnett DK, Beasley TM, Race influences warfarin dose changes associated with genetic factors Blood126:539-45 2015 |
| PubMed ID: 26024874 |
| |
| Limdi NA, Nolin TD, Booth SL, Centi A, Marques MB, Crowley MR, Allon M, Beasley TM, Influence of Kidney Function on Risk of Supratherapeutic International Normalized Ratio-Related Hemorrhage in Warfarin Users: A Prospective Cohort Study American journal of kidney diseases : the official journal of the National Kidney Foundation126:539-45 2014 |
| PubMed ID: 25468385 |
| |
| Limdi NA, McGwin G, Goldstein JA, Beasley TM, Arnett DK, Adler BK, Baird MF, Acton RT, Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin Clinical pharmacology and therapeutics83:312-21 2007 |
| PubMed ID: 17653141 |
|
|